On Nov 2, 2021 Antiva Biosciences closed a Series D round and raised $31,000,000 from Adjuvant Capital, Alexandria Venture Investments, Avestria Ventures, Brace Pharma, Canaan […]
Series D – Cambridge Epigenetix
On Nov 2, 2021 Cambridge Epigenetix closed a Series D round and raised $88,000,000 from Ahren Innovation Capital, GV, New Science Ventures, Sequoia Capital, Temasek […]
Series D – Antiva Biosciences
On Nov 2, 2021 Antiva Biosciences closed a Series D round and raised $31,000,000 from Adjuvant Capital, Alexandria Venture Investments, Avestria Ventures, Brace Pharma, Canaan […]
Series D – Cambridge Epigenetix
On Nov 2, 2021 Cambridge Epigenetix closed a Series D round and raised $88,000,000 from Ahren Innovation Capital, GV, New Science Ventures, Sequoia Capital, Temasek […]
Series C – Lightforce Orthodontics
On Nov 2, 2021 Lightforce Orthodontics closed a Series C round and raised $50,000,000 from AM Ventures, Kleiner Perkins, Matrix Partners, Tyche Partners, featuring lead […]
Series D – Truepill
On Oct 27, 2021 Truepill closed a Series D round and raised $142,000,000 from Initialized Capital, TI Platform Management, featuring lead investors . About the […]
Series C – Cambrian Biopharma
On Oct 26, 2021 Cambrian Biopharma closed a Series C round and raised $100,000,000 from Anthos Capital, Apeiron Investment Group, Future Ventures, Moore Capital, SALT […]
Series C – DNA Script
On Oct 26, 2021 DNA Script closed a Series C round and raised $165,000,000 from Agilent Technologies, Alexandria Venture Investments, ArrowMark Partners, Bpifrance, Casdin Capital, […]
Series D – Medable
On Oct 26, 2021 Medable closed a Series D round and raised $304,000,000 from Blackstone Accelerates Growth, GSR Ventures, Sapphire, Tiger Global Management, Western Technology […]
Series C – Stride Health
On Oct 26, 2021 Stride Health closed a Series C round and raised $47,000,000 from Allstate, Aneesh Chopra, Bruce D. Perkins, Chet Burrell, F-Prime Capital, […]
